Brief: Galapagos Says 9m Net Profit Of Period EUR 48.8 Million
30/10/2024 20:04
Oct 30 (Reuters) - Galapagos NV GLPG.AS :
* GALAPAGOS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
* GALAPAGOS NV - 9M NET PROFIT OF PERIOD EUR 48.8 MILLION
Source text: ID:nGNX714L0W
Further company coverage: GLPG.AS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline